The Depart­ment of Labor issued new guid­ance to delay enforce­ment of a recent rule relat­ed to drug man­u­fac­tur­er coupons. The rul­ing is due to a con­flict it had with an ear­li­er rul­ing, but now there is more con­fu­sion and anoth­er rul­ing is expect­ed lat­er this year.  Under the new inter­pre­ta­tion, insur­ers and plans DO NOT have to count the val­ue of a drug man­u­fac­tur­er coupon toward the annu­al cost shar­ing lim­it when a gener­ic equiv­a­lent is avail­able.  This may imply, how­ev­er, that they DO have to count it when a gener­ic is unavail­able.  Stay tuned.